View Press Releases
-
SGD Pharma launches industry first Ready-to-Use sterile 100 ml molded glass vials in SG® EZ-fill® packaging technology
Puteaux Cedex, FRANCE – 1st March: Worldwide glass primary packaging supplier SGD Pharma has announced the introduction of its 100H* ml Ready-to-Use (RTU) Type I molded glass vials for aseptic fill/finish of parenteral drug products.
Mar 3, 2022
-
Male fertility diagnostics leaders, Examen, now offer semen analysis testing for men in Belfast
Examen, leaders in male fertility research and diagnostics, is delighted to announce that semen analysis is now available at its Belfast facility. This comes in response to unprecedented demand for fertility services as couples continue to face delays in accessing appointments owing to the backlog caused by the pandemic.
Mar 3, 2022
-
Cotiviti to Present on Strategies to Align Payer and Provider Risk Adjustment Programs within Value-Based Care at 2022 RISE National Summit
Summit to be co-chaired by Cotiviti Executive Vice President RaeAnn Grossman
Mar 6, 2022
-
UK Regulator Cites CluePoints’ Solutions in Updated Guidance
UK Regulator Cites CluePoints’ Solutions in Updated Guidance MHRA shares CluePoints case study to demonstrate the value of statistical monitoring in clinical trial oversight and monitoring King of Prussia, PA – 7th March 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has been cited in the updated Good Clinical Practice (GCP) guidance from the UK’s MHRA, putting the agency´s considerable weight behind CluePoints’ industry-leading statistical monitoring solutions.
Mar 6, 2022
-
Alfa Chemistry Announces Completion of Building a Sub-website for Polymer Stabilizers
-
CD Formulation Announces Ability to Achieve Solubility Improvement and Bioavailability Enhancement for Drug Formulation Projects
-
Oxford Medical Products raises £2.5 million for its hydrogel weight-loss platform technology
Oxford Medical Products has raised £2.5M in equity investment to conduct first human trials of Sirona, its innovative non-surgical weight-loss solution. Sirona is a hydrogel-based technology in a tablet format that, once swallowed, expands in the stomach, stops feelings of hunger and suppresses appetite.
Mar 8, 2022
-
Aragen acquires Intox Pvt. Ltd
-
Watson-Marlow Fluid Technology Group drives growth with new Operations and Supply Director
Abdul Butt joins Watson-Marlow Fluid Technology Group as Operations and Supply Director to drive the company’s supply excellence and enable continued growth. Abdul joins the company with extensive experience in Manufacturing and Operational Excellence, including 20 years at GKN PLC and then Melrose Industries as CEO of one of their divisions, followed by MPP where he was Chief Operating Officer in his most recent role.
Mar 9, 2022
-
NanoSyrinx appoints R&D industry leader Dr Marie McAvoy as Chief Scientific Officer
NanoSyrinx has strengthened its management team with the appointment of Dr Marie McAvoy as its Chief Scientific Officer.
Mar 9, 2022
-
Senior Biopharma Executive Joins MMS Holdings as Principal Medical Director
MMS Holdings, a data-focused contract research organization (CRO), announced the addition of Robert Allen, MD, to its team as Principal Medical Director of Global Drug Safety and Pharmacovigilance.
Mar 9, 2022
-
Vyasa Introduces Cortex: Intuitive, Visual Data Fabric Creation & Management
Vyasa, an innovative provider of highly scalable deep learning A.I. analytics software for healthcare, life sciences and business applications, today debuts its latest application, Cortex. An intuitive data management tool, Cortex acts as the “blueprint” of the data fabric by allowing users to build, manage and provision access to data sources connected to Vyasa Layar data fabrics.
Mar 9, 2022
-
Emmes Acquires Casimir, Its Fourth Major Acquisition
-
Japan tops CPhI ‘API Quality’ ranking for second year
-
Alfa Chemistry—A Supplier of Active Pharmaceutical Ingredients
-
Emmes Supports New Collaboration to Accelerate COVID-19 Research for Children
-
mdgroup Listed Among the UK’s Fastest-Scaling Firms in Organic Growth 25 Index
Bracknell, UK – 14th February 2022: mdgroup, a leading global medtech and patient health services company pioneering a patient-first approach to clinical research, has been named as one of the UK's fastest-scaling businesses in 2021's Organic Growth 25 (OG25) index in recognition of its major growth and success, without significant external investment.
Feb 13, 2022
-
mdgroup Appoints Steph Katz as Director of Seacole Health
mdgroup Appoints Steph Katz as Director of Seacole Health Combining Passion for Nursing and Clinical Research to Provide Remarkable Patient Experiences Bracknell, UK: 15 February 2022 - mdgroup, the leading global provider of personalised clinical study services, has appointed Steph Katz as Director of business subsidiary Seacole Health. Seacole Health brings mdgroup’s mobile health and clinical research staff resourcing under one roof. Steph is the ideal person to lead this exciting new venture because of her wealth of healthcare knowledge. Having started as an oncology nurse in intensive care units, Steph achieved her MSN in Nursing Education and began training research coordinators, clinical nurses and fellows. She then took on a management role, helping to develop and operationalize institutional, federal and commercial clinical research projects before pursuing an MBA.
Feb 14, 2022
-
PubHive Unveils New Dashboard for Systematic Review SaaS Solution
AI-powered cloud software platform PubHive Navigator now features a new user dashboard that speeds up systematic literature review workflows for PubHive users
Feb 15, 2022
-
Curebase Adds Two Clinical Trial Veterans to Kick-off New Advisory Board
Curebase, a company committed to democratizing access to clinical studies, has named Dr. Aaron Kamauu and Dr. Amir Lahav to the Curebase Advisory Board.
Feb 15, 2022